ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

12,032Medicare Part D Prescriptions Filled, Including Refills

Rank: 66 out of 1006

$928K Total Retail Price of All Prescriptions

Rank: 48 out of 1006

472 Patients Receiving at Least One Drug in Part D
86%Patients 65 Years and Older
80% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Connecticut
Lower avg

Schedule Two
Controlled Substances

6% of this provider’s 472 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

4% of this provider’s 472 patients filled at least one prescription for a schedule three drug, compared to an average of 4%.

Risky Drugs to Seniors

1% of this provider’s 10,388 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

30% of this provider’s prescriptions were for brand-name drugs, compared to an average of 29%.

Prescription Price

$77 was the average price of a prescription from this provider, compared to $71 among peers.

Prescriptions per Patient

25 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Connecticut
LEVOTHYROXINE SODIUM 425 354 1 2
WARFARIN SODIUM 389 388 2 8
METOPROLOL TARTRATE 376 315 3 7
SIMVASTATIN 356 341 4 1
AMLODIPINE BESYLATE 343 291 5 4
LISINOPRIL 282 254 6 3
FUROSEMIDE 278 255 7 6
TRAZODONE HCL 276 220 8 21
QUETIAPINE FUMARATE 269 232 9 45
ESCITALOPRAM OXALATE 261 217 10 27
SERTRALINE HCL 258 233 11 19
METFORMIN HCL 249 215 12 10
DONEPEZIL HCL 210 209 13 17
ATORVASTATIN CALCIUM 199 177 14 5
GABAPENTIN 189 141 15 20
METOPROLOL SUCCINATE 176 165 16 12
MIRTAZAPINE 155 152 17 26
OMEPRAZOLE 145 126 18 9
NEXIUM 135 128 19 28
ADVAIR DISKUS 128 112 20 37
RISPERIDONE 125 101 21 40
EXELON 114 113 22 99
LANTUS 112 80 23 43
SPIRIVA 108 99 24 48
HYDROCHLOROTHIAZIDE 102 99 25 11
TRAMADOL HCL 93 72 26 35
TAMSULOSIN HCL 90 87 27 23
ALENDRONATE SODIUM 89 80 28 29
DIOVAN 89 82 28 16
SEROQUEL 85 77 30 97
CRESTOR 83 80 31 18
LACTULOSE 82 81 32 104
TRAMADOL HCL-ACETAMINOPHEN 79 77 33 133
IPRATROPIUM-ALBUTEROL 78 74 34 73
ZOLPIDEM TARTRATE 78 76 34 14
ISOSORBIDE MONONITRATE ER 77 77 36 59
METOCLOPRAMIDE HCL 76 75 37 134
ATENOLOL 75 75 38 13
DIVALPROEX SODIUM 72 33 39 53
CARBIDOPA-LEVODOPA 72 59 39 80
POTASSIUM CHLORIDE 71 70 41 30
ABILIFY 70 13 42 102
SYNTHROID 67 60 43 42
ALLOPURINOL 66 66 44 31
JANUVIA 65 61 45 49
NAMENDA 64 58 46 34
LEXAPRO 64 54 46 103
CARVEDILOL 63 62 48 36
CYMBALTA 62 60 49 41
PLAVIX 62 56 49 61
PREDNISONE 59 48 51 33
OLANZAPINE 59 23 51 68
HYDROCODONE-ACETAMINOPHEN 57 34 S3 53 25
SUCRALFATE 57 51 53 297
MELOXICAM 56 46 55 67
CLOPIDOGREL 56 44 55 46
CALCITRIOL 55 43 57 237
PHENYTOIN SODIUM EXTENDED 54 40 58 149
AMIODARONE HCL 53 53 59 168
VESICARE 52 29 60 163
AZITHROMYCIN 50 43 61 39
QUINAPRIL HCL 50 50 61 86
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Sept. 27, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.